This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Clinical Experience -
Outcome of implanting penile prosthesis for treating erectile
dysfunction: experience with 42 cases
Xu-Jun Xuan1,2, Dao-Hu
Wang1, Peng Sun2, Hua
Mei1
1Division of Urology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
2Division of Urology, Shandong Provincial Hospital, Jinan 250021, China
Abstract
Aim: To report a short-time result of three-piece inflatable penile prosthesis (IPP) implantation on treating patients
with organic erectile dysfunction (ED).
Methods: Three-piece IPPs were implanted in 42 Chinese patients with ED
refractory to systemic treatment between May 2002 and May 2004. The etiologies of ED were neurogenic (28 with
paraplegia and seven with traumatic nervi-erigentes injury); congenital venous leakage (5 cases), fibrosis of corpus
cavernosum (1case) and Klinefelter's syndrome (1 case). The follow-up period ranged from 24 to 57 months.
Results: Implantation procedures were successfully performed upon all 42 patients. The length of implanted
prosthesis was from 13 cm to 18 cm, and the diameter was 1 cm. The implanted prosthesis was made by the Medical
Instrumentation Company of Muping (Muping, Shandong, China). Localized infection occurred in only one patient
and mechanical complications occurred in five patients. Coitus could be performed in 41 cases (97.6%). Three
patients with congenital venous leakage made their spouses pregnant after implantation.
Conclusion: Implantation of three-piece IPP is an effective and safe modality for treating patients with ED. It can be well accepted by Chinese
patients because of its efficacy. (Asian J Androl 2007 Sep; 9: 716_719)
Keywords: treatment; erectile dysfunction; penile prosthesis; implantation
Correspondence to: Dr Dao-Hu Wang, Division of Urology, the First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road,
Guangzhou 510080, China.
Tel: +86-20-8733-3300 Fax: +86-20-8733-3300
E-mail: wangdaohu@yahoo.com.cn
Received 2006-09-23 Accepted 2007-01-22
DOI: 10.1111/j.1745-7262.2007.00269.x
1 Introduction
The development of medicine and technology has made it possible to provide new therapeutic modalities for
patients with ED refractory to systemic treatment. The implantation of inflatable penile prostheses
(IPP) for the
treatment of erectile dysfunction (ED) has been widely practiced in the world. As third-line therapy for ED, the
numbers of implants continue to rise as the population of men treated for ED increases [1]. During the past 30 years,
the development of penile prosthesis has ranged from single-piece IPP to three-piece IPP, and from non-inflatable
prosthesis to inflatable prosthesis. Since the 1970s, implantation of three-piece IPP has been considered the gold
standard for the treatment of ED [1].
From the 1990s, some urologists began to treat ED patients in China with the implantation of three-piece IPP
(AMS Company, Minnetonka, NI, USA; or Mentor Company of America, Santa Barbara, CA,
USA), and excellent therapeutic efficacy was achieved. We present our experience of treatment of patients with ED by implantation of
three-piece IPP.
2 Materials and methods
Forty-two Chinese ED patients were enrolled in this
study between May 2002 and May 2004. Among them 35 were neurogenic ED, including 28 with paraplegia
and seven with traumatic nervi-erigentes injury. The rest
included five cases with congenital venous leakage (failure
to store), one with fibrosis of corpus cavernosum, and
one with Klinefelter's syndrome. The age of the
patients was between 23 and 75 years, with an average of
37.2 years. The International Index of Erectile
Function (IIEF-5) [2] was used to evaluate all patients, and
severe ED (scores < 11) was diagnosed to all patients.
Before operation, nocturnal penile tumescence testing
(NPT), Color Doppler flow imaging (CDFI), caver-nosography and sacral nerve sensory evoked potential
(SSEP) were performed, and serum chemistry panel and
hormone profile were collected.
2.1 Preoperative preparation
The sizes of bilateral penile corpus cavernosum,
penile lateriflexion and curvature were assessed before
implantation. The degree of the fibrosis of corpus
cavernosum was also evaluated. Patients and their
spouses were completely informed that implantation of
penile prosthesis was to obtain erection, and this
erection would not be completely the same as those naturally
produced. All patients consented to the procedure.
Prophylactic antibiotic (ciprofloxacin 500 mg, twice daily)
was used for 3 days consecutively before implantation.
2.2 Three-piece IPP
The three-piece IPP used in this study was made by
the Medical Instrumentation Company of Muping (Muping, Shandong, China). This kind of prosthesis was
developed from 1992 to 1994. It was designed
according to the characteristics of Chinese men. The
prosthesis was made from silastic, consisting of a pair of
intracorporeal cylinder, a fluid reservoir and a scrotal
resipump. The three parts are connected by a conduit
(Figure 1). The tissue compatibility and safety of the
prosthesis was tested in animals and humans and approved, and there was no extravasation or leakage (Table
1). The device has been used to treat patient with ED
since 1997. Although its material is a little harder than
imported products, it is accepted well by patients.
2.3 Surgical procedure
Continuous epidural anesthesia was used in our study.
At the connection of penis and scrotum, a transverse
incision of approximately 4 cm in length was used.
Incision was performed in each layer from the skin to penile
corpus cavernosum. Hypodermis and dartos were split
at the urethral laterally. Four stay-sutures with 1-0 SAS
were placed at each penile corpus cavernosum to form
two rows. In between, an incision was carried out
vertically on the penile corpus cavernosum. The penile
corpus cavernosum was dilated with a cervix dilator (diameter
8_13 mm, Pratt size 25_33) from the basilar part of glans
penis to crura penis. The length of the tunnel in the
penile corpus cavernosum was measured with a cylinder embolus, and should have been 0.5_1.0 cm longer
than the penile prosthesis. The management of the other
side was the same. After choosing suitable penile
prosthesis, the prosthesis was inserted into the penile
corpus cavernosum and the incision was closed with
four stitches. The fluid-storing reservoir was placed into
the prevesical space. Then the mediastinum of the
scrotum was divided and the resipump was put in. After
being filled with 40 mL 10% Cystografin, the
fluid-storing reservoir was connected to the resipump. The
resipump was pressed repeatedly to ensure the
successful erection of penis. As soon as the release system of
the resipump was pressed, the penis became flaccid. This
manipulation was carried out 3_4 times to confirm the
installation position was correct and there were no
mechanical troubles. Drainage stayed in the scrotum
before the wound was closed, and the penis was
maintained in semi-erectile status. The procedures were all
performed by the same surgeon.
2.4 Postoperative management
Broad-spectrum antibiotic (ciprofloxacin, 500 mg,
twice daily) was used to prevent infection for 7 days.
Estrogen and hemostatic drugs were used routinely
post-operation. Care was taken postoperatively to observe
whether there was redness, swelling, hematoma or necrosis. The drainage was pulled out on the 4th day
post-operation and the Foley catheter was left in for 7_8
days to prevent contamination of the wound from urine.
The scrotum was elevated to reduce edema. All patients
were discharged within 8 days post-operation. In 6_8
weeks after discharge, patients were instructed on how
to inflate and deflate the device.
3 Results
The procedure was successfully performed upon all
42 patients. The whole procedure took approximately
90_150 min, with an average of 110 min. The length of the
implanted penile prosthesis was 13 cm for one case, 14 cm
for five cases, 15 cm for 18 cases and 16 cm for 18 cases.
The diameter of implanted prosthesis was 1 cm.
Postoperative follow-up lasted for 24_57 months, and 39 months
on average. Localized infection that may have been
caused by fluid extravasation of the prosthesis occurred
in one paraplegia patient at the 11th month after implantation, which resulted in removal of the whole set
of penile prosthesis. Fluid extravasation of penile
prosthesis, which led to removal of the resipump, was
found in another paraplegia patient. Mechanical
complication occurred in three non-paraplegia patients, and the
penis was maintained in semi-erectile status, which was
enough to perform sexual intercourse. Paraplegia
patients adopted the woman-up position during intercourse.
The rate of mechanical failure was 11.9% (5/42) The
effect of intercourse was satisfactory (subjectively) and
the intercourse rate achieved was 97.6% (41/42), which
is higher than that previously reported [3, 4]. Psychogenic
ejaculation occurred in three patients. Four patients with
congenital venous leakage had normal ejaculation after
the treatment. Three spouses fell pregnant.
4 Discussion
The treatment of ED has been revolutionized with
the introduction of orally active phosphodiesterase
inhibitors, which are successful in 70%_80% of men
[5]. However, there remains a group of men in whom
conservative treatment fails and surgical insertion of a
penile prosthesis is required. Thus we reported our
experience with implantation of a prosthesis, made by the
Medical Instrumentation Company of Muping (Muping,
China), for the treatment of patients with ED.
Infection and mechanical failures are the main
complications of the implantation of IPP [6_12] and some
studies even report infection as the most troublesome
complication [1]. By using prophylactic antibiotics
pre-implantation, rigorous procedure, and careful observation,
the postoperative recovery was smooth. There was no
infection in our group at the early stage of post-operation.
Only one patient had infection in the 10th month postoperatively. In order to prevent infection, all
patients were asked to take antibiotics orally for 3 days
every 3 months postoperation, especially for the paraplegia
patients, to prevent the infection of retentive urine.
Although there were 28 ED patients with paraplegia in this
study, the infection rate was as low as 4.76%, which
was lower than that of other reports [3]. The key of the
IPP implantation is to choose an appropriate intracorporeal
cylinder with suitable length and diameter. The length of
penile corpus cavernosum of the Klinefleter's syndrome
patient was only 14 cm, this is very small. As a result,
IPP was only implanted into one cavernosum. The length
of the patient's penis was maintained at 4_5 cm
post-operation and 10_14 cm at erection.
Patients and their spouses were informed that the
erection after implantation would be somehow different
from those naturally produced. Nerve reflection existed
pre-operation would not be affected by implantation.
Paraplegia patients adopted a woman-up position during
sexual intercourse and the effect was satisfactory. To
avoid the resipump in the scrotum stretching excessively
and the fluid-storing reservoir being displaced, patients
were instructed to pay attention to the strength of
inflation and deflation of the device. The displacement of the
device may have been the cause of extravasation of IPP
and mechanical failures in two patients.
In the 1980s, the incidence of mechanical failures in
inflatable penile prosthesis was 10%_20%. In recent
years, this figure has dropped with the development of
technology. Choi et al. [13] reported their experience of
treating ED patients with three-piece inflatable penile
prosthesis in South Korea; the incidence of mechanical
failures in 3 years was 10%. Lewis [14] reported that the
incidence of mechanical failures on AMS700CXM was 5.5% on average. The incidence of mechanical failures
in this study was 11.9% (5/42), including two cases of
fluid extravasation that led to localized infection in one
case, and pump failures occurred in another three cases
at the 18th and 27th month after implantation. The penis
with pump failures was maintained in semi-erectile
status and intercourse could still be performed successfully.
Floccules were found in the fluid of two prostheses by
B-ultrasonograph, indicating that the obstructed valves
caused by floccule might lead to pump failures.
Shortening the exposure time of the fluid to the air may
prevent the formation of floccule. In addition, the
improvement of the prosthesis quality will be helpful in
preventing the incidence of mechanical failures.
In summary, a satisfied result was achieved with
implantation of three-piece IPP to treat Chinese ED
patients. The tissue compatibility and quality of the
penile prosthesis used in this study was proved effective
and can thus be accepted by patients.
References
1 Carson CC. Diagnosis, treatment and prevention of penile
prosthesis infection. Int J Impot Res 2003; 15 Suppl 5:
S139_46.
2 Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM.
Development and evaluation of an abridged, 5-item version of
the International Index of Erectile Function (IIEF-5) as a
diagnostic tool for erectile dysfunction. Int J Impot Res 1999;
11:319_26.
3 Kimoto Y, Iwatsubo E. Penile prostheses for the management
of the neuropathic bladder and sexual dysfunction in spinal
cord injury patients: Long term follow up. Paraplegia
1994;32: 336_9.
4 Akin-Olugbade O, Parker M, Guhring P, Mulhall J.
Determinants of patient satisfaction following penile prosthesis
surgery. J Sex Med 2006; 3: 743_8.
5 Jain S, Terry TR. Penile prosthetic surgery and its role in the
treatment of end-stage erectile dysfunction - an update. Ann
R Coll Surg Engl 2006; 88: 343_8.
6 Montague DK, Angermeier KW. Penile prosthesis
implan-tation. Urol Clin North Am 2001; 28: 355_61.
7 Levine LA, Estrada CR, Morgentaler A. Mechanical reliability
and safety of, and patient satisfaction with the ambicor
inflatable penile prosthesis: results of a 2 center study. J Urol
2001; 166: 932_7.
8 Carson CC, Mulcahy JJ, Govier FE. Efficacy, safety and
patient satisfaction outcomes of the AMS 700CX inflatable
penile prosthesis: results of a long-term multicenter study. AMS
700CX Study Group. J Urol 2000; 164: 376_80.
9 Dubocq F, Tefilli MV, Gheiler EL, Li H, Dhabuwala CB.
Long-term mechanical reliability of multicomponent inflatable
penile prosthesis: Comparison of device survival. Urology
1998; 52: 277_81.
10 Govier FE, Gibbons RP, Correa RJ, Pritchett TR,
Kramer-Levien D. Mechanical reliability, surgical complications, and
patient and partner satisfaction of the modern three-piece
inflatable penile prosthesis. Urology 1998; 52: 282_6.
11 Abouassaly R, Montague DK, Angermeier KW.
Antibiotic-coated medical devices: with an emphasis on inflatable penile
prosthesis. Asian J Androl 2004; 6: 249_57.
12 Minervini A, Ralph DJ, Pryor JP. Outcome of penile
prosthesis implantation for treating erectile dysfunction: experience
with 504 procedures. BJU Int 2006; 97: 129_33.
13 Choi HK, Cho IR, Xin ZC. Ten years of experience with
various penile prosthesis in korean. Yonsei Med J 1994;
35:209_17.
14 Lewis RW. Long-term results of penile prosthetic implants.
Urol Clin North Am 1995; 22: 847_56.
|